AFL

Prezzo Aflac Inc

AFL
$0
+$0(0,00%)
Nessun dato

*Data last updated: 2026-04-28 19:11 (UTC+8)

As of 2026-04-28 19:11, Aflac Inc (AFL) is priced at $0, with a total market cap of $59,08B, a P/E ratio of 16,03, and a dividend yield of 2,04%. Today, the stock price fluctuated between $0 and $0. The current price is 0,00% above the day's low and 0,00% below the day's high, with a trading volume of 1,17M. Over the past 52 weeks, AFL has traded between $0 to $0, and the current price is 0,00% away from the 52-week high.

AFL Key Stats

Yesterday's Close$114
Market Cap$59,08B
Volume1,17M
P/E Ratio16,03
Dividend Yield (TTM)2,04%
Dividend Amount$0
Diluted EPS (TTM)6,87
Net Income (FY)$3,64B
Revenue (FY)$17,43B
Earnings Date2026-04-29
EPS Estimate1,81
Revenue Estimate$4,18B
Shares Outstanding515,45M
Beta (1Y)0.652
Ex-Dividend Date2026-02-18
Dividend Payment Date2026-03-02

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
SectorFinancial Services
IndustryInsurance - Life
CEODaniel Paul Amos
HeadquartersColumbus,GA,US
Official Websitehttps://www.aflac.com
Employees (FY)12,71K
Average Revenue (1Y)$1,37M
Net Income per Employee$286,72K

Aflac Inc (AFL) FAQ

What's the stock price of Aflac Inc (AFL) today?

x
Aflac Inc (AFL) is currently trading at $0, with a 24h change of 0,00%. The 52-week trading range is $0–$0.

What are the 52-week high and low prices for Aflac Inc (AFL)?

x

What is the price-to-earnings (P/E) ratio of Aflac Inc (AFL)? What does it indicate?

x

What is the market cap of Aflac Inc (AFL)?

x

What is the most recent quarterly earnings per share (EPS) for Aflac Inc (AFL)?

x

Should you buy or sell Aflac Inc (AFL) now?

x

What factors can affect the stock price of Aflac Inc (AFL)?

x

How to buy Aflac Inc (AFL) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Aflac Inc (AFL)

TechubNews

TechubNews

04-26 22:39
Pulse Biosciences ($PLSE) 在“Heart Rhythm 2026”会议上公布了其 nPulse 心脏导管的首次人体可行性研究结果。本次发布中最引人注目的部分是手术成功率和安全性。6个月时的手术成功率为95例中95例,达到100%;12个月时,53例中51例成功,成功率为96%。 公司表示,这项研究作为针对房颤(AF)治疗的早期临床数据具有重要意义。1年时的Kaplan-Meier分析显示,无房颤(AF)、房扑(AFL)和房性心动过速(AT)的比例为90%。严重不良事件(SAE)在总共177例中发生3例,发生率为1.7%。 手术效率指标也相对良好。左心房内器械停留时间平均为18.6±13.0分钟,总手术时间为60.2±27.7分钟。透视时间为9.4±5.9分钟,实现肺静脉隔离(PVI)的平均能量应用次数为12.3±2.6次。在常规房颤手术中,手术时间和透视时间的缩短会影响医护人员的疲劳度、患者负担以及医院运营效率,因此这些数值足以引起市场关注。 这一结果被解读为衡量Pulse Biosciences能否在心脏电生理领域证明其技术竞争力的早期指标。目前仍处于早期可行性研究阶段,因此需要更大规模的后继临床试验和长期随访数据,但仅从已公布的数据来看,“成功率”和“安全性”均符合预期。如果后续临床试验能取得类似结果,该公司在房颤治疗设备市场的存在感可能会增强。 TP AI注意事项 本文基于TokenPost.ai语言模型进行摘要。主要文本内容可能被遗漏或与事实不符。
0
0
0
0
SelfRugger

SelfRugger

04-25 10:13
This is a paid press release. Contact the press release distributor directly with any inquiries. From Diagnosis to Ringing the Bell ================================== Aflac Incorporated Wed, February 18, 2026 at 11:00 PM GMT+9 1 min read In this article: AFL +0.44% **NORTHAMPTON, MA / ACCESS Newswire / February 18, 2026 / **Originally published on Aflac Newsroom Alex was diagnosed with a rare rhabdoid tumor on his left kidney, a condition that only affects about 25 people per year globally. With a survival rate of 10-15%, Alex underwent surgery to remove the tumor and began chemotherapy. After two years of treatment at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, he was able to celebrate the completion of his care journey by ringing the bell. "Being at the Aflac Cancer Center was very comforting ... They all are just so supportive and helpful and, honestly, I don't know how any family could do it without the support that they provide there," said Alex's dad, James Schoomaker. Watch Alex' story above to learn more about his journey. Aflac Incorporated Alex and the Schoomaker family represent the "why" in Aflac's long-standing commitment to children with cancer and blood disorders like sickle cell disease. Since 1995, Aflac agents, employees and The Aflac Foundation, Inc. have given more than $195 million to The Aflac Cancer and Blood Disorders Center. Every donation to the Aflac Cancer and Blood Disorder Center helps fund lifesaving research that is shared with hospitals across the U.S. to give children, like Alex, a chance at life. Learn more by visiting AflacChildhoodCancer.org. Aflac WWHQ |1932 Wynnton Road | Columbus, GA 31999 Z2600100 EXP 2/27 Find more stories and multimedia from Aflac Incorporated at 3blmedia.com. **Contact Info:** Spokesperson: Aflac Incorporated Website: Email: info@3blmedia.com **SOURCE: **Aflac Incorporated View the original press release on ACCESS Newswire 條款 及 私隱政策 Privacy Dashboard More Info
0
0
0
0